Jean-Pierre Kinet

VAXON Biotech SA develops therapeutic vaccines for the treatment of cancers. It offers treatment for lung, gastric, prostate, breast, renal, liver, and colorectal cancers, using its proprietary technology of optimized cryptic peptides. The firm also provides research and development services. The company was founded by Konstantinos Kosmatopoulos in 2004 and is headquartered in Paris, France.

Genewave SAS developed, manufactured and marketed microarray instrumentation for the molecular diagnostic and life sciences markets. The company was founded by Claude Weisbuch, Henri Benisty and Francois Vallet in December 2001 and was headquartered in Evry, France.

Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions.

Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France.

iXBlue SAS manufactures navigation systems using high-spec fiber-optic gyroscopes. The firm offers surface gyrocompasses, photonic components and modules, motion simulators, stabilized platforms, testing and calibration tables, optical fibers and modulators, surface and unmanned underwater vehicle navigators, and space sensors. The company was founded on September 27, 2000 and is headquartered in Saint-Germain-en-Laye, France.

iXCore deals with marine, aeronautics, and fund industries. It offers in maritime, land and space industry, biotechnology, and investment. The company was founded on September 21, 2001 and is headquartered in Marly-le-Roi, IF.

ATANIS Biotech AG is a company based in Oberkirch, Germany that provides a functional allergy diagnostic screening test. The German company's mission is to revolutionize the way allergies are diagnosed and improve treatment success. The company is driven by scientific excellence and provide a proprietary mast cell line that functions as an ex vivo alternative to in vivo testing. Noemi Bachmeier-Zbären, Jean-Pierre Kinet has been the CEOs since 2021. The company was founded in 2021 by Alexander Eggel, Thomas Kaufmann, Noemi Bachmeier-Zbären, Jean-Pierre Kinet.